Alia Anne Poore is a pharmacist who is specialized in Critical Care in Cleveland, Ohio. Patients can reach her at 10701 East Blvd, Cleveland or contact her on 216-791-3800. Active license number of Alia Anne Poore is 03328602 for Critical Care in Ohio. Alia Anne Poore is a licensed pharmacist who has demonstrated specialized knowledge and skill in the delivery of patient care services by pharmacists, as integral members of interprofessional teams, working to ensure the safe and effective use of medications in critically ill patients.
Complete Profile:
Alia Anne Poore speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Alia Anne Poore
Specialization:
Critical Care
Credentials:
PHARMD
Gender:
Female
Location:
10701 East Blvd, Cleveland, Ohio, 44106-1702
Phone:
216-791-3800
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Alia Anne Poore are as mentioned below.
NPI Number:
1508327511
NPI Enumeration Date:
31 Mar, 2019
NPI Last Update On:
16 Oct, 2023
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Alia Anne Poore are as mentioned below.
Specialization
License Number
State
Status
Critical Care
03328602
Ohio
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
26620 Strawberry Ln, Westlake, Ohio
Zip:
44145-5420
Phone Number:
216-374-6061
Fax Number:
--
Patients can reach Alia Anne Poore at 10701 East Blvd, Cleveland, Ohio or can call on phone at 216-791-3800.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.